Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GOLGA2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GOLGA2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GOLGA2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of GOLGA2 mRNA | increases expression | 20458559
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GOLGA2 mRNA | decreases expression | 20018196
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GOLGA2 mRNA | affects cotreatment|decreases expression | 20360939
|
D002330 |
Carmustine |
Carmustine results in decreased expression of GOLGA2 mRNA | decreases expression | 15980968
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GOLGA2 mRNA | increases expression | 20106945
|
D004040 |
Dietary Carbohydrates |
Dietary Carbohydrates results in decreased expression of GOLGA2 mRNA | decreases expression | 17490981
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GOLGA2 mRNA | affects cotreatment|decreases expression | 20360939
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA2 mRNA | affects cotreatment|increases expression | 17942748
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GOLGA2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of GOLGA2 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA2 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GOLGA2 protein | increases expression | 12361703
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GOLGA2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.48 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.48 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.31 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.31 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.87 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.59 | 19061943 17620307 19052882 18056438 17162532 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.59 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.59 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.59 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18558336 16609825 17507914 17157402 18316065 18775368 20603192 18177632 18985861 19460635 15238991 18940202 18396377 19232924 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.09 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.46 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.08 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.08 | 8888407 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.41 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.97 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.36 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.59 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.59 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
6.59 | 11135700 16217749 15073043 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.59 | 20214788 18056438 17761372 20512989 19208518 16681979 19701751 17428255 19171122 17162532 16935385 18665156 16288022 21159647 17173139 20935162 10672840 20524982 17978847 18971187 19539802 10737359 19052882 19383236 17138121 20432363 18393292 19519916 17055752 11831363 16569478 16807293 18506893 20084675 18210153 18494052 19919837 16698587 20514400 19822196 16502159 19335982 16328049 19418558 18788625 3581430 20727157 20007298 16878318 19107877 18978308 16830150 20101231 3084413 16540662 18785209 16779866 18691550 19394651 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.94 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.14 | 12490120 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.60 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.17 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.17 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.17 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
16.17 | 2727394 7505956 17174075 21159647 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.41 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.47 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.47 | 16919318 17333356 16105132 15861022 17681005 17110522 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.47 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 15668235 12621046 16354765 8697196 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.22 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.78 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.78 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.78 | 16575769 17688650 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.06 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.13 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.24 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.24 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.10 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.10 | 18071297 14550746 16227642 11529661 16177239 11743745 16109766 12540782 12705907 19923254 10915739 11739529 17522070 12153990 15968718 19164858 16081117 16485898 11834606 18713872 19085960 19420014 12958197 19370779 11421492 12594235 14986274 12392966 14725611 17562736 11461765 15619225 17906064 10774834 19416960 10663392 19739265 16393943 16781746 2444490 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.10 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.10 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.10 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.22 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.19 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.98 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.95 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.34 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.11 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.48 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.48 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
31.17 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
31.17 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
31.17 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
31.17 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
31.17 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
31.17 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.30 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
3.94 | 16187019 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 16120746 12621046 15340226 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.81 | 17440010 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16354765 8697196 16959395 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.50 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.94 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.94 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.61 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.20 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
10.20 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.20 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.35 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.35 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.84 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.82 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.36 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.45 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.79 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.92 | 16467208 16968895 20471514 17050201 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.92 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.00 | 19075265 12018890 9834237 17217047 17712046 15336539 16823087 16330433 11468182 15748426 19642359 16331271 16891316 12679006 16112521 15622746 19035177 17649720 12712474 16966277 17107899 17869043 15213294 19225113 11161223 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
8.00 | 16766008 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.39 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.84 | 18407596 18522880 19638242 18665156 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.14 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.14 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.93 | 19784758 16610002 19460945 11587558 19014921 12587719 12969438 16611625 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.93 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.34 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
14.34 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.34 | 19499222 19996281 18648771 19850985 19254457 2422723 20137499 20492335 12771043 19427195 12112319 20118626 19812893 16942905 20452335 9163691 19690152 19256749 18754104 19073162 19426721 2862719 21278145 19551842 15175105 21047994 20101389 20501860 19638242 10737359 18977376 18978307 19642983 19833225 21167192 19255062 21071580 20583210 19294768 20405173 19090486 20434301 18644402 15885732 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.34 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.25 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.25 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.25 | 18775883 18079962 3124819 18544905 19126423 19539802 18253720 16267830 16842330 19009564 18164116 18308698 21159647 17942915 19519916 9362446 18093689 18282651 17854601 2563599 19004024 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.25 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.40 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.40 | 20970405 6695378 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.40 | 19555203 11884234 |
MESH:D008545 |
Melanoma |
|
Carmustine |
2.87 | 12393984 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18765137 18803445 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.12 | 15949261 19417148 11468182 19549372 14977855 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.73 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.47 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.47 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.00 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.58 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.96 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.39 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.39 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.26 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.26 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.46 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.41 | 19769630 16624393 12452020 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.30 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.30 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.19 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.03 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.03 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.63 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.63 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.27 | 19131511 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.60 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.00 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.00 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.00 | 3137016 11738929 11044598 16876388 1511512 15475178 14763951 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.80 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.45 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.45 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.26 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.26 | 7505956 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.01 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.12 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.12 | 11780464 20435036 12845720 12973940 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.37 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |